Treatment & ER Protocols: Managing the Attack Safely
Last updated:
Managing hemiplegic migraine requires fast action and avoiding typical migraine drugs like triptans. Patients should use non-vasoconstrictive acute medications, explore daily preventives, and carry an ER protocol letter to prevent dangerous misdiagnoses and unsafe stroke treatments.
Key Takeaways
- • Act fast during an attack by notifying someone immediately, finding a dark room, and taking prescribed acute medications.
- • Triptans, ergotamines, and estrogen-based birth control are generally avoided in hemiplegic migraine.
- • Safe acute treatments may include high-dose NSAIDs, intravenous magnesium, or non-vasoconstrictive drugs like ditans.
- • Daily preventive medications like flunarizine, acetazolamide, or anti-epileptic drugs can help reduce attack frequency.
- • Patients should carry an ER protocol letter from their neurologist to ensure safe emergency treatment and avoid misdiagnosis.
Managing hemiplegic migraine (HM) requires a different approach than typical migraines. Because HM symptoms mimic a stroke, having a clear medical plan—including what to take and, more importantly, what to avoid—is essential for your safety [1][2].
The Home Action Plan
When an attack begins, fast action is necessary. Because symptoms like aphasia (inability to speak) can come on quickly, you should:
- Notify Someone Immediately: Tell a family member or coworker the moment you feel the aura start, before you lose the ability to communicate.
- Get to a Safe Place: Lie down in a dark, quiet room to minimize sensory input.
- Take Your Medication: Take your prescribed acute medication (like an NSAID) immediately, exactly as directed by your neurologist.
The Safety Warning: What to Avoid
- Triptans and Ergotamines: For many years, these vasoconstrictors (which narrow blood vessels) have been the “gold standard” for typical migraines [3]. However, in HM, doctors are concerned these drugs could restrict blood flow further during the “brain tsunami” phase. They are traditionally contraindicated and generally avoided by ER doctors, though you should follow your specific headache specialist’s guidance [3][4].
- Estrogen-Based Birth Control: If you are a female patient, it is critical to know that migraine with aura (especially HM) carries a significantly higher stroke risk when combined with estrogen-based contraceptives (like combination birth control pills). Discuss progesterone-only or non-hormonal options with your doctor immediately [1].
Acute Treatment: Safe Alternatives
Your doctor may suggest these alternatives for treating an attack as it happens:
- Symptomatic Control: High-dose NSAIDs (like ibuprofen or ketorolac) and anti-emetics are often used [5][6].
- Intravenous (IV) Magnesium: Some clinical reports suggest IV magnesium can be effective for severe attacks [7].
- Non-Vasoconstrictive Options: Newer drugs like ditans (e.g., lasmiditan) do not cause blood vessel narrowing and may be a safer choice [8][9].
Preventive Care: Reducing the Frequency
If attacks are frequent or severe, your doctor may recommend a daily medication.
- Flunarizine: Often considered a standard preventive for HM, this calcium channel blocker can help reduce how often attacks occur [10][11].
- Acetazolamide: A classic, frequently utilized preventive medication specifically for familial hemiplegic migraine (especially the FHM1 subtype) [12].
- Anti-Epileptic Drugs (AEDs): Medications like Topiramate, Lamotrigine, or Valproate are used to stabilize brain activity [6][11].
- CGRP Monoclonal Antibodies: New preventive drugs (like fremanezumab) are showing promise in early case reports [13][14].
The ER Protocol: Your “Migraine Passport”
One of the biggest challenges with HM is being misdiagnosed in the ER. To advocate for yourself and ensure safety, carry an ER Protocol Letter (also called a “migraine passport”) from your neurologist [1][15].
Your letter should include:
- Your confirmed diagnosis (FHM or SHM) and known genetic mutations [1][6].
- Your typical symptoms: Describe your specific pattern of one-sided weakness and duration [1].
- A strict warning against tPA (clot-busters): The letter must explicitly state that you have HM to help ER staff avoid administering unnecessary and dangerous stroke medications like tPA, which carry an unwarranted risk of severe hemorrhage in HM patients [1].
- A list of “No-Go” drugs: Note that triptans and ergotamines are generally avoided [1].
- Recommended treatments: Provide the ER doctor with your neurologist’s preferred plan [1].
Frequently Asked Questions
What medications should I avoid if I have hemiplegic migraine?
How do I stop a hemiplegic migraine attack?
Can I use triptans for hemiplegic migraine?
What is a migraine passport for the ER?
Are there daily preventative medicines for hemiplegic migraine?
Questions for Your Doctor
- • Can you provide me with a personalized ER protocol letter that explicitly states my diagnosis and lists contraindicated medications?
- • Is intravenous magnesium or valproate an option for me if I have a severe attack that won't stop?
- • Since I shouldn't take triptans, would a 'ditan' (like lasmiditan) or a 'gepant' be a safer acute alternative for me?
- • What is your preferred preventive treatment plan (e.g., flunarizine, acetazolamide, or topiramate) based on my specific genetic profile?
- • If my child has a severe attack with fever or confusion, at what point should we seek hospital admission versus monitoring at home?
Questions for You
- • Do you carry a 'migraine passport' or a medical ID that identifies you as having hemiplegic migraine?
- • Have you noticed which medications have worked best for you in the past to reduce the duration of weakness?
- • Are you aware of the specific signs that mean you need to go to the ER versus staying at home (e.g., high fever, severe confusion)?
- • How often are you experiencing attacks, and is it time to discuss a daily preventive medication with your doctor?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Familial Hemiplegic Migraine Type 3 (FHM3) With an SCN1A Mutation in a Chinese Family: A Case Report.
Shao N, Zhang H, Wang X, et al.
Frontiers in neurology 2018; (9()):976 doi:10.3389/fneur.2018.00976.
PMID: 30498473 - 2
Familial hemiplegic migraine type 2: a case report of an adolescent with ATP1A2 mutation.
Zhang H, Jiang L, Xian Y, Yang S
Frontiers in neurology 2024; (15()):1339642 doi:10.3389/fneur.2024.1339642.
PMID: 38379707 - 3
Migraine in the era of precision medicine.
Zhang LM, Dong Z, Yu SY
Annals of translational medicine 2016; (4(6)):105 doi:10.21037/atm.2016.03.13.
PMID: 27127758 - 4
Migraine Aura-Catch Me If You Can with EEG and MRI-A Narrative Review.
Riederer F, Beiersdorf J, Scutelnic A, Schankin CJ
Diagnostics (Basel, Switzerland) 2023; (13(17)) doi:10.3390/diagnostics13172844.
PMID: 37685382 - 5
[Familial hemiplegic migraine].
Starikova NL, Kulesh AA
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2021; (121(7)):114-117 doi:10.17116/jnevro2021121071114.
PMID: 34460166 - 6
Familial hemiplegic migraine in Indian children-a tertiary center experience.
Saini L, Gunasekaran PK, Tiwari S, et al.
Journal of tropical pediatrics 2024; (70(3)) doi:10.1093/tropej/fmae008.
PMID: 38580379 - 7
Treatment of CACNA1A Encephalopathy and Cerebral Edema with Magnesium and Dexamethasone.
Turner C, Campbell L, Fung R, et al.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2024; 1-4 doi:10.1017/cjn.2024.52.
PMID: 39157864 - 8
Acute Treatment of Migraine: What has Changed in Pharmacotherapies?
Yang CP, Huang KT, Chang CM, et al.
Neurology India 2021; (69(Supplement)):S25-S42 doi:10.4103/0028-3886.315995.
PMID: 34003146 - 9
Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist.
Joyner KR, Morgan KW
The Annals of pharmacotherapy 2021; (55(6)):745-759 doi:10.1177/1060028020963574.
PMID: 32993366 - 10
Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK.
Karsan N, Palethorpe D, Rattanawong W, et al.
European journal of neurology 2018; (25(6)):811-817 doi:10.1111/ene.13621.
PMID: 29512871 - 11
Relationships between migraine and epilepsy: Pathophysiological mechanisms and clinical implications.
Demarquay G, Rheims S
Revue neurologique 2021; (177(7)):791-800 doi:10.1016/j.neurol.2021.06.004.
PMID: 34340811 - 12
R1352Q CACNA1A Variant in a Patient with Sporadic Hemiplegic Migraine, Ataxia, Seizures and Cerebral Oedema: A Case Report.
Stubberud A, O'Connor E, Tronvik E, et al.
Case reports in neurology 2021; (13(1)):123-130 doi:10.1159/000512275.
PMID: 33790770 - 13
Reduced Frequency of Prolonged Sporadic Hemiplegic Migraine Attacks Following Fremanezumab Treatment-A Case Report.
Hotz JF, Kaindl L, Krebs S, et al.
European journal of neurology 2026; (33(2)):e70514 doi:10.1111/ene.70514.
PMID: 41589756 - 14
Efficacy of anti-calcitonin gene-related peptide monoclonal antibodies in hemiplegic migraine: a case report and review of literature.
Héja M, Oláh L
Frontiers in neurology 2025; (16()):1579203 doi:10.3389/fneur.2025.1579203.
PMID: 40264646 - 15
Haploinsufficiency of PRRT2 Leading to Familial Hemiplegic Migraine in Chromosome 16p11.2 Deletion Syndrome.
Sen K, Genser I, DiFazio M, DiSabella M
Neuropediatrics 2022; (53(4)):279-282 doi:10.1055/a-1863-1798.
PMID: 35617967
This page provides educational information on hemiplegic migraine management and emergency protocols. Always consult your neurologist to create a personalized treatment plan and medical passport.
Stay up to date
Get notified when new research about Familial or sporadic hemiplegic migraine is published.
No spam. Unsubscribe anytime.